Overview
Enovix Corporation is a U.S.-based company located in Fremont, California. It operates primarily in the energy sector, focusing on the development and manufacturing of advanced silicon-anode lithium-ion batteries. These high-energy-density batteries are designed to significantly enhance storage capacity and efficiency, catering to the demands of modern electronic devices and electric vehicles. A key project for Enovic includes the creation of 3D cell architecture, which aims to improve safety and performance over conventional batteries. Through ongoing development and innovation, Enovix strives to tackle some of the most pressing challenges in battery technology, positioning itself as a leader in next-generation battery solutions.
AI+ Ask Fintel’s AI assistant about Enovix Corporation.
Thinking about good questions…
Basic Stats
The share price of Enovix Corporation as of September 5, 2025 is $9.19 / share. This is a decrease of -4.47% from the prior week. The market cap (or net worth) of Enovix Corporation as of September 5, 2025 is $1,774.25 MM.
The Factor Analysis chart (below right) shows a view of Enovix Corporation from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 1,774.25 MM |
| EV | 1,821.23 MM |
| Shares Out. | 192.96 MM |
| Earnings Date | |
| EPS (TTM) | -0.66 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 0.72 |
| Short Shares Avail. | 7.80 MM |
| Short Interest | 45.30 MM |
| Short Float | 26.20 % |
| Days to Cover | 11.03 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | 12.82 % |
| Volatility (1 yr) | 0.90 |
| Beta | 2.29 |
| Sharpe Ratio (1 yr) | 0.10 |
| Sortino Ratio (1 yr) | 0.17 |
| PE Ratio | -13.86 |
| Price/Book | 8.59 |
| Price/TBV | 11.26 |
| Book/Market | 0.12 |
| EBIT/EV | -0.07 |
| EBIT(3yr avg)/EV | -0.11 |
| ROA | -0.26 |
| ROE | -0.74 |
| ROIC | -0.32 |
| CROIC | -0.25 |
| OCROIC | -0.22 |
| Implied Volatility | 86.85 % |
| Put/Call OI Ratio | 0.30 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Enovix Corporation is $29.89. The forecasts range from a low of $10.10 to a high of $105.00. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Enovix Corporation. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2022-12-02 | B. Riley Securities | Buy | Initiate | |
| 2022-11-04 | Janney Montgomery Scott | Buy | Initiate | |
| 2022-10-28 | EF Hutton | Buy | Initiate | |
| 2022-08-24 | Cowen & Co. | Outperform | Maintains | |
| 2022-08-22 | Loop Capital | Buy | Maintains | |
| 2022-08-11 | Northland Capital Markets | Outperform | Maintains | |
| 2022-08-11 | Craig-Hallum | Buy | Maintains | |
| 2022-08-05 | JP Morgan | Overweight | Initiate | |
| 2022-06-24 | Cowen & Co. | Outperform | Maintains | |
| 2022-03-04 | Craig-Hallum | Buy | Maintains | |
| 2022-01-04 | Cowen & Co. | Outperform | Initiate | |
| 2021-12-17 | Piper Sandler | Overweight | Initiate | |
| 2021-12-02 | Craig-Hallum | Buy | Initiate | |
| 2021-08-17 | Oppenheimer | Outperform | Initiate | |
| 2023-01-23 | Piper Sandler | Overweight | Maintains | |
| 2023-01-11 | Canaccord Genuity | Buy | Initiate | |
| 2023-01-27 | EF Hutton | Buy | Maintains | |
| 2023-01-26 | JP Morgan | Overweight | Maintains | |
| 2023-02-23 | Craig-Hallum | Buy | Maintains | |
| 2023-02-23 | Piper Sandler | Overweight | Maintains | |
| 2023-02-23 | EF Hutton | Buy | Reiterate | |
| 2023-03-10 | Cantor Fitzgerald | Overweight | Reiterate | |
| 2023-03-29 | EF Hutton | Buy | Reiterate | |
| 2023-05-05 | Baird | Outperform | Maintains | |
| 2023-04-27 | Oppenheimer | Outperform | Reiterate | |
| 2023-04-27 | EF Hutton | Buy | Maintains | |
| 2023-06-16 | Canaccord Genuity | Buy | Buy | Reiterate |
| 2023-09-08 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-09-21 | EF Hutton | Buy | Buy | Reiterate |
| 2023-06-28 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-07-21 | TD Cowen | Outperform | Market Perform | Downgrade |
| 2023-07-20 | B. Riley Securities | Buy | Buy | Maintains |
| 2023-07-27 | Craig-Hallum | Buy | Buy | Maintains |
| 2023-07-27 | EF Hutton | Buy | Buy | Reiterate |
| 2023-11-08 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2024-04-26 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-02-21 | EF Hutton | Buy | Buy | Reiterate |
| 2024-02-21 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-02-21 | Canaccord Genuity | Buy | Buy | Reiterate |
| 2024-04-30 | B. Riley Securities | Buy | Buy | Maintains |
| 2024-01-18 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-05-02 | Craig-Hallum | Buy | Buy | Maintains |
| 2024-05-02 | EF Hutton | Buy | Buy | Maintains |
| 2024-04-25 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-06-27 | Canaccord Genuity | Buy | Buy | Maintains |
| 2024-08-01 | Canaccord Genuity | Buy | Buy | Maintains |
| 2024-08-01 | Craig-Hallum | Buy | Buy | Maintains |
| 2024-08-01 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-08-01 | TD Cowen | Hold | Hold | Maintains |
| 2024-10-31 | Janney Montgomery Scott | Buy | Neutral | Downgrade |
| 2025-04-29 | B. Riley Securities | Buy | Buy | Maintains |
| 2024-08-05 | Piper Sandler | Overweight | Overweight | Reiterate |
| 2024-08-26 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-07-22 | Benchmark | Buy | Initiate | |
| 2025-02-20 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2025-02-20 | Craig-Hallum | Buy | Buy | Maintains |
| 2024-10-22 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-04-15 | Benchmark | Buy | Buy | Maintains |
| 2025-04-24 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-10-30 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-10-30 | Benchmark | Buy | Buy | Reiterate |
| 2025-07-24 | JP Morgan | Overweight | Neutral | Downgrade |
| 2025-07-10 | B. Riley Securities | Buy | Buy | Maintains |
| 2025-05-01 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-05-01 | TD Securities | Hold | Hold | Maintains |
| 2025-07-25 | Benchmark | Buy | Buy | Maintains |
| 2025-07-08 | Craig-Hallum | Buy | Buy | Maintains |
| 2025-08-04 | Canaccord Genuity | Buy | Buy | Maintains |
